Anti‐Yo‐associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of unknown origin
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Anti-Yo-associated paraneoplastic cerebellar degeneration (PCD) is almost invariably associated with breast or gynecologic tumors. 1 In this syndrome, anti-Yo autoantibodies react with 34- and 62-kd antigens simultaneously expressed by tumor and Purkinje cells. 2 Using immunohistochemistry, similar staining (although not always identical) antibodies have been found and named by others PCA-1 and type I antineuronal antibodies. 3 Only one male patient, in whom no tumor was found, has been reported with anti-Yo-associated PCD. 4 We report another man with anti-Yo-associated PCD in the context of a carcinoma of unknown origin. A nonenzymatic method to unmask antigens in paraffin-embedded tissue helped to demonstrate that the tumor expressed Yo antigens.
Case report
A 68-year-old right-handed man with a medical history of heavy tobacco and alcohol use presented to the neurology clinic with a 2-month history of progressively unsteady gait and frequent falls. He denied heavy alcohol use over this period.
On physical examination he had gynecomastia and normal male genitalia except for an undescended testis. There was severe bilateral dysmetria involving only the legs, without weakness or sensory loss. A repeat examination 1 month later demonstrated progression of symptoms. It also showed dysarthria with scanning speech, multidirectional gaze-evoked nystagmus, …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Differences in Age-related Retinal and Cortical Atrophy Rates in Multiple Sclerosis
Prof. Massimo Filippi and Dr. Paolo Preziosa
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Correspondence
Neuronal calcium channel autoantibodies coexisting with type 1 Purkinje cell cytoplasmic autoantibodies (PCA-1 or "anti-Yo")Vanda A. Lennon, Thomas J. Kryzer et al.Neurology, July 01, 1998 -
Brief Communications
Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodiesI. Rojas, F. Graus, F. Keime-Guibert et al.Neurology, September 12, 2000 -
Clinical/Scientific Notes
Paraneoplastic cerebellar degeneration associated with noncutaneous Merkel cell carcinomaCen Zhang, Lyndsey Emery, Eric Lancaster et al.Neurology - Neuroimmunology Neuroinflammation, July 03, 2014 -
Articles
Absence of antibodies to non-NMDA glutamate-receptor subunits in paraneoplastic cerebellar degenerationA. Degenhardt, R. M. Duvoisin, J. Frennier et al.Neurology, May 01, 1998